COVID-19 NEWS


Research and industry collaboration in full swing

The National Research and Innovation Strategy aims to encourage companies to undertake research, development and innovation activities. In order to make research a driver for economic diversification and for innovation in industry, the government encourages the development of public-private partnership programmes. Recently, the Luxembourg Institute of Science and Technology (LIST) and the University of Luxembourg’s Interdisciplinary Centre […]

Europe must come together to confront Omicron

A multi-disciplinary team of over 30 scientists from all across Europe, including Research Luxembourg spokesman Paul Wilmes, have joined forces to issue a statement to address the wave of the Omicron variant of SARS-CoV-2. The statement was published in the renowned British Medical Journal (BMJ) on January 11, 2022. In their call to coordinated action, […]

What are the benefits, costs and feasibility of a low incidence COVID-19 strategy

The rate of fully vaccinated people is not sufficient to break infection chains and reduce infection rates in most European countries. What’s more, the emerging variants of concern show partial immune escape. What’s the cost of high incidence? What does a low incidence strategy imply? In a recently published open access paper, a collective of […]

Research Luxembourg scientists contribute to international Covid-19 work

As a testimony to the excellence and openness to the world of Luxembourg research, two projects conducted by researchers in the Luxembourg Institute of Health (LIH) and the Luxembourg Institute of Socio-Economic Research (LISER) have recently contributed to international Covid-19 research. Predi-COVID study included in worldwide unCoVer network Launched two years ago, the Predi-COVID study […]

Survey reveals 87% of Luxembourg vaccinees are eager to get a booster jab or already got it

How many vaccinated people want to get a booster jab? How many parents have had their children vaccinated? A recent representative survey conducted by the Luxembourg National Research Fund (FNR)/science.lu in cooperation with researchers from Luxembourg gives answers to these questions and more generally on vaccination. Luxembourg vaccinees willing to get a booster dose Among vaccinees in Luxembourg, […]

CON-VINCE: Luxembourg population willing to help science

What is the nature, prevalence and mode of transmission of COVID-19 in Luxembourg? CON-VINCE was launched in April 2020 as one of multiple initiatives under the Research Luxembourg COVID-19 task force to help control the pandemic. By screening a statistically representative panel of volunteers for the presence of the SARS-CoV-2 virus, the study aims to […]

What does Covid-19 sound like?

COVID-19 strongly affects breathing and voice. Indeed, it causes symptoms that make patients’ voices distinctive, creating recognisable audio signatures. Initial studies have already suggested the potential of using voice as a screening solution. Unlike other related research that mainly tries to show that a particular machine learning model is suitable for a COVID-19 detection task, […]

Monitoring SARS-CoV-2 in wastewater

Monitoring SARS-CoV-2 in wastewater has shown to be an effective tool for epidemiological surveillance. Yet, monitoring individual lineages circulating in the population based on genomic sequencing of wastewater samples is challenging. In a new paper, the Luxembourg Institute of Science and Technology and the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg, along with […]

Research Luxembourg and government together during the pandemic

On 5 October 2021, the Prime Minister of Luxembourg Xavier Bettel and Research Luxembourg COVID-19 Taskforce met to discuss the milestones of their collaboration while looking at the actions carried out and to come. Mobilising research towards the same objective Between March and May 2020, Research Luxembourg managed to bring together the best of research […]